Senthil Kumar Ganesan

6PUBLICATIONS
16CO-AUTHORS
Tumour immunologyCell metabolismCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 20, 2026
S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors.

Debashree Basak, Puspendu Ghosh, Anupam Gautam

|Apr 30, 2021
β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.

Selvaraj Jayaraman, Nalini Devarajan, Ponnulakshmi Rajagopal

|Feb 09, 2021
Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies.

Nalini Devarajan, Selvaraj Jayaraman, Jaideep Mahendra

|Sep 03, 2020
Increased mortality of COVID-19 infected diabetes patients: role of furin proteases.

Senthil Kumar Ganesan, Purushothaman Venkatratnam, Jaideep Mahendra

|Nov 15, 2019
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.

Devarajan Nalini, Jayaraman Selvaraj, Ganesan Senthil Kumar

|Sep 19, 2019
Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy.

Nidhi Kumari, Aditi Karmakar, Senthil Kumar Ganesan

Pageof 1

Frequent Collaborators

1 joint publications

Nalini Devarajan

1 joint publications

Selvaraj Jayaraman

1 joint publications

Shyamaladevi Babu

1 joint publications

Chella Perumal Palanisamy